Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex‐specific differences in myocardial injury incidence after COVID‐19 mRNA‐1273 booster vaccination
Natacha Buergin, Pedro López‐Ayala, Julia R. Hirsiger, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 10, pp. 1871-1881
Open Access | Times Cited: 22

Showing 22 citing articles:

‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis
Nicolas Hulscher, Roger Hodkinson, William Makis, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 28
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
Determinants of COVID-19 vaccine-induced myocarditis
Jessica Rose, Nicolas Hulscher, Peter A. McCullough
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 12
Elasomeran

Reactions Weekly (2025) Vol. 2049, Iss. 1, pp. 146-146
Closed Access
The Role and Implications of COVID-19 in Incident and Prevalent Heart Failure
Juan Simón Rico-Mesa, Justin Haloot, B K Anupama, et al.
Current Heart Failure Reports (2024)
Closed Access | Times Cited: 2
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Comparative Risks Cardiovascular Adverse Events of COVID-19 and other Vaccines
Kirstin Cosgrove, James A. Thorp, Kirk A Milhoan, et al.
The Gazette of Medical Sciences (2024) Vol. 5, Iss. 1, pp. 50-60
Open Access | Times Cited: 1
Myocarditis Associated with COVID-19 Vaccination
Kamila Florek, Mateusz Sokolski
Vaccines (2024) Vol. 12, Iss. 10, pp. 1193-1193
Open Access | Times Cited: 1
Myocardial injury related to SARS‐CoV‐2 mRNA vaccination: The plot thickens
N. Levi, Tal Hasin
European Journal of Heart Failure (2023) Vol. 25, Iss. 10, pp. 1882-1883
Closed Access | Times Cited: 3
Gene-based COVID-19 vaccines: Australian perspectives in a corporate and global context
Peter Rhodes, Peter Parry
Pathology - Research and Practice (2023) Vol. 253, pp. 155030-155030
Open Access | Times Cited: 3
Case of Myocarditis, Pericarditis, and Fatal Aortic Dissection following Covid-19 mRNA Vaccination
Eduardo J Balbona, Heather Hudson, Janci Lindsay, et al.
(2024)
Open Access
IL-1RA autoantibodies: insights into mechanisms and associated diseases
Abdellatif Bouayad
American Journal of Translational Research (2024) Vol. 16, Iss. 2, pp. 374-386
Open Access
Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: a prospective study on subtle and persistent cardiovascular involvement
Martin Möckel, Samipa Pudasaini, Ngoc Han Le, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Vaccine Impact Bonds: An Alternative Way of Allocating the Economic Risks of Mass Vaccination Programs
Pascal R. M. Kubin
HEC Forum (2024)
Closed Access
Case Report: Cryptic evidence on underreporting of mRNA vaccine-induced myocarditis in the elderly: a need to modify antihypertensive therapy
Donald R. Forsdyke
(2024)
Open Access
Reports Of Autopsies In VAERS And Associated Adverse Events Linked To Cause Of Death
Jessica Rose
(2024)
Open Access
Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: monitoring cardiovascular safety of COVID-19 vaccination
Samipa Pudasaini, Ngoc Han Le, Dörte Huscher, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
The WHO Algorithm for Causality Assessment of Adverse Effects Following Immunization with Genetic-Based Anti-COVID-19 Vaccines: Pitfalls and Suggestions for Improvement
Paolo Bellavite, Alberto Donzelli, Ciro Isidoro
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7291-7291
Open Access
The impact of myocardial injury on outcomes in TAVI patients
Thorald Stolte, Pedro López‐Ayala, Jakob Reichl, et al.
Clinical Research in Cardiology (2024)
Open Access
Commentary: raised c-troponin levels as a sign of myocardial injury after COVID-19 vaccination in healthy individuals are worrying
Rainer J. Klement, Harald Walach
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access
Criticism of the HAS Opinion of July 21st, 2022, on Maintaining of the SARS-Cov-2 Vaccine Mandate for Healthcare Workers
Jérôme Sainton
Coronaviruses (2023) Vol. 4, Iss. 2
Closed Access
October 2023 at a glance: From prevention to diagnosis, prognosis and treatment of acute decompensation and comorbidities
Daniela Tomasoni, Marianna Adamo, Marco Metra
European Journal of Heart Failure (2023) Vol. 25, Iss. 10, pp. 1719-1721
Closed Access
Page 1

Scroll to top